Product Information

KETOROLAC 60 MG/2 ML VIAL is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $0.6167 per ML under NDC 68462075725. Its NADAC has been published 119 times since Aug 7, 2024.

FDA first approved this application on May 10, 2023. Its Orange Book therapeutic-equivalence code is AP.

KETOROLAC 60 MG/2 ML VIAL

ketorolac tromethamine
$0.6167per ML

Strength

60 mg/2mL

NDC

68462075725

Classification

Generic

Dosage Form

INJECTION, SOLUTION

Route

INTRAMUSCULAR

Effective Date

10/21/2026

Active Ingredients

KETOROLAC TROMETHAMINE

Approval Type

Generic (ANDA)

FDA Application

ANDA217789

FDA Approved

5/10/2023

TE Code

AP

On Market Since

2/1/2024

Pharmacological Classes

Anti-Inflammatory Agents
Non-Steroidal
Cyclooxygenase Inhibitor
Cyclooxygenase Inhibitors
Nonsteroidal Anti-inflammatory Drug

Price Statistics

The NADAC for KETOROLAC 60 MG/2 ML VIAL has been published 119 times since Aug 7, 2024, and over the history we have for it it has declined 10.3%. The table below summarizes its recorded NADAC range and movement.

Current price$0.6167 per ML
All-time high$0.6982 (Dec 11, 2024)
All-time low$0.4543 (Feb 18, 2026)
52-week high$0.6167
52-week low$0.4543
Median price$0.5738
Average price$0.5769
Largest weekly change+11.7% (Nov 20, 2024)
Weeks tracked119
Tracking sinceAug 7, 2024

Price History

1W

0.0%

1M

+11.6%

3M

+28.3%

6M

+21.2%

1Y

+13.4%

3Y

N/A

5Y

N/A

All

-10.3%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 19% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of KETOROLAC 60 MG/2 ML VIAL?

The current National Average Drug Acquisition Cost (NADAC) for KETOROLAC 60 MG/2 ML VIAL, manufactured by Glenmark Pharmaceuticals Inc., USA, is $0.6167 per ML (NDC 68462075725), effective Nov 11, 2026.

How has the price of KETOROLAC 60 MG/2 ML VIAL changed over time?

Over the history we have for it, the NADAC for KETOROLAC 60 MG/2 ML VIAL has declined 10.3%. It has been tracked across 119 weekly CMS publications since Aug 7, 2024.

What are the highest and lowest recorded NADAC prices for KETOROLAC 60 MG/2 ML VIAL?

Since Aug 7, 2024, the NADAC for KETOROLAC 60 MG/2 ML VIAL has ranged from a low of $0.4543 (Feb 18, 2026) to a high of $0.6982 (Dec 11, 2024), with a median of $0.5738 per ML.

Are there cheaper alternatives to KETOROLAC 60 MG/2 ML VIAL?

Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, KETOROLAC 60 MG/2 ML VIAL, is $0.4980 per ML — about 19% below KETOROLAC 60 MG/2 ML VIAL.

Who manufactures KETOROLAC 60 MG/2 ML VIAL?

KETOROLAC 60 MG/2 ML VIAL (NDC 68462075725) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.